Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extra oxygen boosts walking distance for lung patients?

NCT ID NCT07451977

Knowledge-focused Sponsor: Istituti Clinici Scientifici Maugeri SpA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving extra oxygen during a 6-minute walk test helps people with chronic lung disease walk farther and feel better. About 114 adults with conditions like COPD or interstitial lung disease will do two walking tests—one with their usual oxygen and one with extra oxygen. The goal is to learn how to better prescribe oxygen for exercise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 114 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of chronic respiratory disease admitted for pulmonary rehabilitation * One of the following conditions at discharge: * Chronic obstructive pulmonary disease with exertional hypoxemia * Chronic obstructive pulmonary disease with chronic respiratory failure requiring long-term oxygen therapy * Interstitial lung disease with chronic respiratory failure requiring long-term oxygen therapy * Clinically stable condition for at least one month * Optimized medical therapy during hospitalization * Ability to perform the 6-minute walk test * Signed informed consent Exclusion Criteria: * Lung diseases other than chronic obstructive pulmonary disease or interstitial lung disease * Resting oxygen flow requirement greater than 4 liters per minute * Orthopedic, neurological, or cognitive conditions that may limit walking performance * Recent cardiovascular or cerebrovascular events within the previous 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Hypoxia interstitial lung disease respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease (COPD) Chronic respiratory failure Hypoxemia Interstitial lung disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Bari

    RECRUITING

    Bari, 70124, Italy

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Lumezzane

    RECRUITING

    Lumezzane, Brescia, 25065, Italy

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Montescano

    RECRUITING

    Montescano, Pavia, 27040, Italy

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Pavia

    RECRUITING

    Pavia, 27100, Italy

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Veruno

    NOT_YET_RECRUITING

    Veruno, Novara, 28013, Italy

  • Istituti Clinici Maugeri , Respiratory rehabilitation of the Institute of Marina di Ginosa

    NOT_YET_RECRUITING

    Taranto, 74025, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.